Brigham and Women's Hospital is the second largest teaching hospital of Harvard Medical School and the largest hospital in the Longwood Medical Area in Boston, Massachusetts.

There are 793 beds in Brigham and Women's Hospital.

During the past decade, Brigham and Women's Hospital conducted 1102 clinical trials. In the 10-year time frame, 1102 clinical trials started and 618 clinical trials were completed, i.e. on average, 56.1% percent of trials that started reached the finish line to date. In the past 5 years, 528 clinical trials started and 301 clinical trials were completed. i.e. 57% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brigham and Women's Hospital" #1 sponsor was "Brigham and Women's Hospital" with 649 trials, followed by "Dana-Farber Cancer Institute" with 153 trials sponsored, "National Cancer Institute (NCI)" with 89 trials sponsored, "Pfizer" with 68 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 68 trials sponsored. Other sponsors include 1027 different institutions and companies that sponsored additional 456 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brigham and Women's Hospital" #1 collaborator was "Brigham and Women's Hospital" with 135 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 135 trials as a collaborator, "National Cancer Institute (NCI)" with 82 trials as a collaborator, "Massachusetts General Hospital" with 59 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 46 trials as a collaborator. Other collaborators include 1697 different institutions and companies that were collaborators in the rest 742 trials.

According to Clinical.Site data, the most researched conditions in "Brigham and Women's Hospital" are "HIV Infections" (73 trials), "Asthma" (46 trials), "Heart Failure" (46 trials), "Coronary Artery Disease" (39 trials) and "Hypertension" (37 trials). Many other conditions were trialed in "Brigham and Women's Hospital" in a lesser frequency.

Most popular intervention types in "Brigham and Women's Hospital" are "Drug" (1072 trials), "Other" (363 trials), "Device" (285 trials), "Procedure" (182 trials) and "Behavioral" (161 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (258 trials), "Laboratory Biomarker Analysis" (48 trials), "placebo" (38 trials), "Quality-of-Life Assessment" (25 trials) and "Cisplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "Brigham and Women's Hospital" are 1814 trials for "All" genders, 189 trials for "Female" genders and 53 trials for "Male" genders.

Currently, there are 624 active trials in "Brigham and Women's Hospital". 19 are not yet recruiting, 325 are recruiting, 265 are Active, not recruiting, and 15 are Enrolling by invitation. In total, there were 1072 completed trials in Brigham and Women's Hospital, 9 suspended trials, and 196 terminated clinical trials to date.

Out of the total trials that were conducted in Brigham and Women's Hospital, 195 "Phase 1" clinical trials were conducted, 477 "Phase 2" clinical trials and 384 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 121 trials, and there were also 589 trials that are defined as “Not Applicable".

Brigham and Women's Hospital has several departments that took part in Clinical trials: "Dana Farber Cancer Institute/Brigham and Women's Hospital" - 43 trials, "Dana-Farber/Brigham and Women's Cancer Center" - 39 trials, "Dana-Farber/Brigham and Women's Cancer Center at South Shore" - 34 trials, "Brigham and Women's Hospital - Infectious Diseases" - 15 trials, "Sleep Disorders Research Program Brigham and Women's Hospital" - 13 trials, "Brigham and Women's Hospital , Department of Neurology" - 7 trials, "Boston Children's Hospital, Brigham & Women's Hospital" - 7 trials, "Brigham and Women's Hospital Pain Management Center" - 5 trials, "Translational Pain Research, Brigham and Women's Hospital" - 5 trials, "Brigham and Women's Hosp. Novel Adenoviral Vector Prophylactic HIV Vaccine Non-Network CRS" - 3 trials, "Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital" - 3 trials, "Weiner Center for Preoperative Evaluation" - 3 trials, "Brigham and Women's Hospital, Division of Sleep Medicine" - 3 trials, "Brigham and Women's Hospital, Department of Orthopedic Surgery" - 3 trials, "Brigham & Women's Hospital: Department of Medicine, Rheumatology, Immunology" - 3 trials, "Brigham and Women's Hospital - Crohn's and Colitis Center" - 3 trials, "Southern Jamaica Plain Health Center" - 2 trials, "Brigham and Women's Hospital, Shapiro Cardiovascular Center" - 2 trials, "Brookside Community Health Center" - 2 trials, "Brigham and Women's Hospital, Department of Dermatology" - 2 trials, "Cartilage Repair Center, Brigham and Women's Hospital" - 2 trials, "Movement Disorders Clinic, 60 Fenwood Road" - 2 trials